List of bibliographic references
Number of relevant bibliographic references: 38.
[0-20] [
0 - 20][
0 - 38][
20-37][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000700 (2014) |
Arthur A. Stone [États-Unis] ; Stefan Schneider ; Joan E. Broderick ; Joseph E. Schwartz | Single-day pain assessments as clinical outcomes: not so fast. |
| 000702 (2014) |
Peng Zhang [États-Unis] ; Jianqin Lu ; Yixian Huang ; Wenchen Zhao ; Yifei Zhang ; Xiaolan Zhang ; Jiang Li ; Raman Venkataramanan ; Xiang Gao ; Song Li | Design and evaluation of a PEGylated lipopeptide equipped with drug-interactive motifs as an improved drug carrier. |
| 000812 (2014) |
José Pablo Leone [États-Unis] ; Julieta Leone ; Carlos Teodoro Vallejo ; Juan Eduardo Pérez ; Alberto Omar Romero ; Mario Raul Machiavelli ; Luis Romero Acu A ; María Ester Domínguez ; Mario Langui ; Hebe Margot Fasce ; Bernardo Amadeo Leone ; Eduardo Ortiz ; Julián Iturbe ; Ariel Osvaldo Zwenger | Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience. |
| 000C07 (2014) |
Sandra M. Swain [États-Unis] | Reply to E.J. Moylan et al |
| 000C08 (2014) |
Adrian V. Lee ; Nancy E. Davidson | Breast Cancer in 2013: Genomics, drug approval pathways, and optimal treatment duration |
| 000C25 (2014) |
Matthew J. Sikora ; Kristine L. Cooper ; Amir Bahreini ; Soumya Luthra ; Guoying Wang ; Uma R. Chandran ; Nancy E. Davidson ; David J. Dabbs ; Alana L. Welm ; Steffi Oesterreich | Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response |
| 000C81 (2014) |
Stefan Aebi ; Shari Gelber ; Stewart J. Anderson ; István Láng ; André Robidoux ; Miguel Martín ; Johan W. R. Nortier ; Alexander H. G. Paterson ; Mothaffar F. Rimawi ; José Manuel Baena Ca Ada ; Beat Thürlimann ; Elizabeth Murray ; Eleftherios P. Mamounas ; Charles E. Geyer ; Karen N. Price ; Alan S. Coates ; Richard D. Gelber ; Priya Rastogi ; Norman Wolmark ; Irene L. Wapnir | Chemotherapy for Isolated Locoregional Recurrence of Breast Cancer: The CALOR Randomised Trial |
| 001040 (2014) |
Uma Krishnamurti [États-Unis] ; Jan F. Silverman | HER2 in breast cancer: a review and update. |
| 001277 (2014) |
Stephanie R. Land [États-Unis] ; Qing Liu [États-Unis] ; D. Lawrence Wickerham [États-Unis] ; Joseph P. Costantino [États-Unis] ; Patricia A. Ganz [États-Unis] | Cigarette smoking, physical activity, and alcohol consumption as predictors of cancer incidence among women at high risk of breast cancer in the NSABP P-1 Trial |
| 001625 (2014) |
Aju Mathew [États-Unis] ; Adam Brufsky [États-Unis] | The bone substudy of MA.27: does bone make a difference? |
| 001B15 (2014) |
Arumugam Nagalingam [États-Unis] ; Panjamurthy Kuppusamy [États-Unis] ; Shivendra V. Singh [États-Unis] ; Dipali Sharma [États-Unis] ; Neeraj K. Saxena [États-Unis] | Mechanistic elucidation of the antitumor properties of withaferin A in breast cancer |
| 001D21 (2014) |
Catherine M. Bender ; Amanda L. Gentry ; Adam M. Brufsky ; Frances E. Casillo ; Susan M. Cohen ; Meredith M. Dailey ; Heidi S. Donovan ; Jacqueline Dunbar-Jacob ; Rachel C. Jankowitz ; Margaret Q. Rosenzweig ; Paula R. Sherwood ; Susan M. Sereika | Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer. |
| 001E77 (2014) |
Sharon H. Giordano [États-Unis] ; Sarah Temin [États-Unis] ; Jeffrey J. Kirshner [États-Unis] ; Sarat Chandarlapaty [États-Unis] ; Jennie R. Crews [États-Unis] ; Nancy E. Davidson [États-Unis] ; Francisco J. Esteva [États-Unis] ; Ana M. Gonzalez-Angulo [États-Unis] ; Ian Krop [États-Unis] ; Jennifer Levinson [États-Unis] ; Nancy U. Lin [États-Unis] ; Shanu Modi [États-Unis] ; Debra A. Patt [États-Unis] ; Edith A. Perez [États-Unis] ; Jane Perlmutter [États-Unis] ; Naren Ramakrishna [États-Unis] ; Eric P. Winer [États-Unis] | Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline. |
| 001F93 (2014) |
Amanda M. Clark [États-Unis] ; Sarah E. Wheeler [États-Unis] ; Donald P. Taylor [États-Unis] ; Venkateswaran C. Pillai [États-Unis] ; Carissa L. Young [États-Unis] ; Rachelle Prantil-Baun [États-Unis] ; Transon Nguyen [États-Unis] ; Donna B. Stolz [États-Unis] ; Jeffrey T. Borenstein [États-Unis] ; Douglas A. Lauffenburger [États-Unis] ; Raman Venkataramanan [États-Unis] ; Linda G. Griffith [États-Unis] ; Alan Wells [États-Unis] | A Microphysiological System Model of Therapy for Liver Micrometastases |
| 002003 (2015) |
Aju Mathew [États-Unis] ; Adam Brufsky [États-Unis] | Bisphosphonates in breast cancer. |
| 002167 (2014) |
Adam M. Brufsky | Predictive and Prognostic Value of the 21-Gene Recurrence Score in Hormone Receptor–positive, Node-positive Breast Cancer |
| 002214 (????) |
Adam M. Brufsky [États-Unis] | Managing postmenopausal women with hormone receptor-positive advanced breast cancer who progress on endocrine therapies with inhibitors of the PI3K pathway. |
| 002239 (2014) |
Harold J. Burstein ; Sarah Temin ; Holly Anderson ; Thomas A. Buchholz ; Nancy E. Davidson ; Karen E. Gelmon ; Sharon H. Giordano ; Clifford A. Hudis ; Diana Rowden ; Alexander J. Solky ; Vered Stearns ; Eric P. Winer ; Jennifer J. Griggs | Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update |
| 002376 (2014) |
Tadeu Ambros [États-Unis] ; Simon B. Zeichner ; John Zaravinos ; Alberto J. Montero ; Eugene Ahn ; Mani Aruna ; Lori Kronish ; Reshma L. Mahtani ; Charles L. Vogel | A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancer. |
| 002829 (2014) |
Xiaolan Zhang [États-Unis] ; Yixian Huang [États-Unis] ; Wenchen Zhao ; Yichao Chen [États-Unis] ; Peng Zhang [États-Unis] ; Jiang Li [États-Unis] ; Raman Venkataramanan ; Song Li [États-Unis] | PEG-Farnesyl Thiosalicylic Acid Telodendrimer Micelles
as an Improved Formulation for Targeted Delivery of Paclitaxel |
| 002A07 (2014) |
Sharon Wilks [États-Unis] ; Shannon Puhalla [États-Unis] ; Joyce O'Shaughnessy [États-Unis] ; Lee Schwartzberg [États-Unis] ; Erhan Berrak [États-Unis] ; James Song [États-Unis] ; David Cox [États-Unis] ; Linda Vahdat [États-Unis] | Phase 2, multicenter, single-arm study of eribulin mesylate with trastuzumab as first-line therapy for locally recurrent or metastatic HER2-positive breast cancer. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Breast Neoplasms (drug therapy)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i \
-Sk "Breast Neoplasms (drug therapy)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= Ncbi
|étape= Curation
|type= indexItem
|index= KwdEn.i
|clé= Breast Neoplasms (drug therapy)
}}
| This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021 |  |
